Back of the Napkin presents another great chapter in the story of targeted protein degradation (TPD). Join Alessio Ciulli, Founder and Director at the Centre for Targeted Protein Degradation, in his adventures in unlocking the secrets of TPD that are revolutionizing disease treatment. Listen now: https://apple.co/3BlrOKp or https://spoti.fi/4eyRBNw
Bio-Techne
Biotechnology Research
Minneapolis, Minnesota 50,224 followers
Empowering scientists & clinicians by providing high-quality reagents, analytical instruments, & precision diagnostics.
About us
Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products. Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our growth has been accelerated through acquisitions, organic investments, diversification of our customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net sales of over $1.1 billion. Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.
- Website
-
http://www.bio-techne.com/
External link for Bio-Techne
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Minneapolis, Minnesota
- Type
- Public Company
Locations
-
Primary
614 McKinley Place NE
Minneapolis, Minnesota 55413, US
Employees at Bio-Techne
-
Brett Houser
-
Geoffrey Grove (林杰富)
Senior Product Manager
-
Andrew Stobbe
Senior IT Manager & DevOps SRE Leader | Driving Innovation in Web Ops & Platform Development
-
Kurt Donner
Business Leader - Spatial Genomics & Multiomics - Gene Therapy - Cell Therapy - RNAi/ASO - Biomarkers - Single-cell Biology - Life Sciences - Biotech…
Updates
-
A library of 240 compounds for GPCR research. Combining pharmacological and chemical diversity, it is designed for HTS, HCS, target validation and assay development. Learn More - https://bit.ly/3TFoQXJ #drugdiscovery, #drugdevelopment, #screening, #compoundlibraries
-
Achieve greater assay sensitivity! In this application note, explore how utilizing high sensitivity mode on the INTELLIFLEX® instrument combined with R&D Systems™ Luminex® assays, can expand analyte detection and ensure more precise and reliable data, enabling improved experimental design and decision making— particularly for multifaceted studies like signaling pathway analysis and multi-parameter immune profiling. https://bit.ly/3Ba7Hit #Luminex #BioTechne #Multiplexing
-
Stem Cell experts, Barbara Corneo and DEBORAH FRENCH use the Human Pluripotent Stem Cell Identification Kit from Bio-Techne to verify the pluripotency of their starting stem cells. Learn more about how this kit can support your stem cell research! https://bit.ly/3XRggHS #stemcell #iPS #differentiation #pluripotency #cultrex #regenmed
-
Our scientists are excited to showcase their latest neuroscience research at #SfN24! Explore their posters throughout the meeting, covering interneuron heterogeneity, biofluid biomarker quantification, and more. Get the full details: https://lnkd.in/djAm-49S
-
The Spatial Biology Week™ hosted by Lunaphore, a Bio-Techne brand is back! Open to everyone, our free virtual event will feature talks from 15 top experts across diverse research fields and applications. Whether you're interested in attending a single session or the full week, don’t miss this unique opportunity to gain valuable insights and expand your knowledge. Register now to secure your spot: https://bit.ly/4efZtnq
-
Jennifer Petter is a biotech innovator and founder of Arrakis Therapeutics. Hear her story of building a company around therapeutic opportunities for RNA targeting small molecules. This exciting new drug modality can help revolutionize treatments for cancer, infectious disease, and beyond. Listen now: https://spoti.fi/3X23ggZ or https://apple.co/47e3ar9
-
"All Great Truths Begin as Blasphemies” a quote from George Bernard Shaw that inspired BotN guest Jennifer Petter to take on the unimaginable task of finding small molecule therapeutics targeting RNA. 🎤 Listen now on: https://spoti.fi/4etUUpi or https://apple.co/47e3ar9!
-
We had a great time connecting with you at CE-Pharm. We look forward to bringing you more exciting insights on the MauriceFlex system next year. Explore MauriceFlex: https://bit.ly/4da7uZK #cepharm2024 #innovation #biotechne
-
Discover our 2024 Corporate Sustainability Report: https://bit.ly/3Txjgq8. Our mission is to improve the quality of life by catalyzing advances in science and medicine. We achieve this through our innovative product portfolio and through our commitment to developing our people, supporting our communities, and becoming a more sustainable company.